[1]
Jayaswal, M., Kumar, V. and Agarwal, A.K. 2024. Tolvaptan, an Oral Vasopressin Antagonist, in Treatment of Hyponatremia in Cirrhosis. Patna Journal of Medicine. 98, 1 (Dec. 2024), 38–43.